13-Cis-retinoic acid plus interferon-alpha 2a in recurrent respiratory papillomatosis

J Natl Cancer Inst. 1994 Jun 1;86(11):859-61. doi: 10.1093/jnci/86.11.859.

Authors

S M Lippman¹, D T Donovan, R A Frankenthaler, R S Weber, C L Earley, W K Hong, H Goepfert

Affiliation

¹ Department of Thoracic/Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.

PMID: 8182767
DOI: 10.1093/jnci/86.11.859

No abstract available

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Child
Humans
Interferon alpha-2
Interferon-alpha / administration & dosage
Isotretinoin / administration & dosage
Neoplasm Recurrence, Local / drug therapy
Neoplasm Recurrence, Local / pathology
Papilloma / drug therapy*
Papilloma / pathology
Pilot Projects
Prospective Studies
Recombinant Proteins
Respiratory Tract Neoplasms / drug therapy*
Respiratory Tract Neoplasms / pathology
Severity of Illness Index
Treatment Outcome

Substances

Interferon alpha-2
Interferon-alpha
Recombinant Proteins
Isotretinoin